second level header image

N e w  H o r i z o n s   F o r u m

New Horizons

Speeding the development of new therapies and diagnostics for glaucoma patients.

Friday, February 9, 2024
7:00 AM – 7:00 PM
Westin St. Francis San Francisco on Union Square


New Horizons Forum is a full day of presentations, panels, and discussions featuring CEOs from start-up companies, industry executives, ophthalmic leaders, venture capitalists, and the FDA. Presented by the Glaucoma Research Foundation, this annual catalyst meeting is designed to bring the essential components together to speed the translation of new ideas into clinical practice.

Play Video

Keynote Speaker

The 2024 Drs. Henry and Frederick Sutro Memorial Lecture at New Horizons Forum will be announced soon.

new horizons speaker 2023

"I would encourage anyone who hasn't been to this meeting to put on your calendar and consider coming, because it is an opportunity to reconnect with colleagues in a way that is going to generate new ideas."

Eve J. Higginbotham, SM, MD, Vice Dean for Penn Medicine Office of Inclusion, Diversity, and Equity, Perelman School of Medicine, University of Pennsylvania

Program agenda

New Horizons Forum unites clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.

View the 2023 New Horizons Forum Agenda.

"This forum is one place where we see the collaboration between clinicians, scientists, investors, big strategics and venture capitalists, and patients, all together in one room to see and evaluate what's coming up in the new horizon."

Ike K. Ahmed, MD, Assistant Professor. Ophthalmology & Vision Sciences, University of Toronto

Who should



•  Early-stage CEOs and executives
•  Business development and other representatives from companies thatoffer pharmaceuticals, devices, drugdelivery, and IOP monitoring
•  Key opinion leaders and leading ophthalmologists
•  Industry executives
•  Venture capitalists
•  Representatives from clinical research organizations
• Scientific innovators 


Nationally and internationally respected leaders in the field of glaucoma, business, and medical innovation provide leadership for the Glaucoma 360 New Horizons Forum. The leadership includes Co-founders Andrew Iwach, MD and Adrienne Graves, PhD, an elite Steering Committee, the New Horizons Advisory Board, and the New Horizons Program Committee. 

View the Leadership for New Horizons Forum.

"It's a collegial atmosphere. Everyone is communicating with each other. Everybody is enjoying their time together. New Horizons is a fun meeting to attend, and you learn a lot."

Lama Al-Aswad, MD, MPH, Professor of Ophthalmology and Professor of Population Health at NYU Langone Health

Apply to be a
presenting company

Do you have a new technology or glaucoma innovation to present?

To submit your application to be a presenting company at New Horizons Forum in 2024, please complete the application here.

"I would encourage any glaucoma practitioner to attend New Horizons Forum to get excited about what we do. Taking care of glaucoma day in and day out can be very discouraging, but coming to New Horizons and Glaucoma 360 creates that sense of hope and excitement about the future."

Ruth Williams, MD, Glaucoma Specialist, Wheaton Eye Clinic

“What sets this meeting apart from other ophthalmology meetings is its emphasis on innovation. It's exciting to see what the future holds. It makes me a lot more hopeful about the future of glaucoma care.”

Eydie Miller-Ellis, MD, Director of Glaucoma Services, Scheie Eye Institute


All Glaucoma 360 events will be held at Westin St. Francis San Francisco on Union Square, 335 Powell Street, San Francisco.

“An outstanding mix of basic science, clinical studies, and industry perspectives. Wonderfully congenial atmosphere.”

Larry Benowitz, PhD, Boston Children's Hospital and Harvard Medical School

Frequently Asked Questions

The 2024 New Horizons Forum is an “in-person only” event. New Horizons Forum will not be live streamed, and it will not be possible to attend virtually this year.

If you need to update your registration with an attendee replacement, please send us an email with the details of your registration and who will be attending in your place. ​If you are unable to attend, a written email request including your full name must be received in our events mailbox  by Thursday, January 25, 2024 to receive a refund. There is a cancellation processing fee of $75 per person. The deadline for cancellation/refund requests is January 25, 2024. No refund requests will be accepted after this date.

Unvaccinated individuals will not be able to attend, including those with medical or religious exemptions for vaccination.

By February 8, 2024, you must be two weeks past your final dose in the primary series of COVID-19 vaccinations. In most cases this means you will need to have completed your primary series of vaccinations by January 24, 2024. Any of the accepted vaccines listed on the WHO Emergency Use List will be accepted for entry to Glaucoma 360 if the final shot is completed by January 24, 2024.

Glaucoma Research Foundation is committed to everyone’s safety at Glaucoma 360. Therefore, proof of COVID-19 vaccination will be required for all attendees, exhibitors, staff, and contractors. Due to the fluidity of the current situation, additional safety protocols for Glaucoma 360 may be announced closer to the meeting. All decisions are based on best practices as recommended by the Centers for Disease Control and Prevention (CDC), as well as from both the State of California and City of San Francisco. In addition, all attendees are encouraged to be current with their COVID-19 vaccine boosters.

If you would like to reserve a hotel room, please contact the Westin St. Francis San Francisco directly. The Westin St. Francis is located at 335 Powell Street on Union Square in San Francisco. Please contact the hotel for room reservations.

Please see the transportation and parking information on the Venue page of this website.

All proceeds from Glaucoma 360 benefit Glaucoma Research Foundation, a 501(c)(3) national nonprofit. 

Glaucoma Research Foundation (GRF) is a national non-profit organization dedicated to finding a cure for glaucoma. Founded in 1978 in San Francisco, GRF funds results-oriented innovative research and provides definitive educational materials for glaucoma patients and eye care professionals. Research initiatives include the collaborative Catalyst for a Cure research consortium and the Shaffer Grants for Innovative Glaucoma Research. Patient Education programs include the annual Glaucoma Patient Summit and the comprehensive website.

Glaucoma 360 is the inspiration of Adrienne Graves, PhD and Andrew Iwach, MD, who are both members of the Glaucoma Research Foundation Board of Directors. Dr. Graves is a visual scientist by training, a global industry leader in ophthalmology, and the former CEO of Santen Inc. Dr. Iwach, GRF’s Board Chair, is Executive Director of the Glaucoma Center of San Francisco, Associate Clinical Professor of Ophthalmology at the University of California at San Francisco, and a faculty instructor at the California Pacific Medical Center Department of Ophthalmology. 

COVID-19 Health and Safety Information
Proof of full COVID-19 vaccination will be required to attend Glaucoma 360 events. Attendees are encouraged to also receive a COVID-19 vaccine booster. Attendees should review all CDC Guidelines and should not attend if they are not fully vaccinated or if they are experiencing any symptoms of COVID-19.

Attendees will receive their name badge from event staff following their vaccination check as proof that they have completed the vaccination verification process. If you have questions, please send us an email.